Research Topics
| Victor MusiimeSummaryCountry: UK Publications
| Collaborators
|
Detail Information
Publications
Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan childrenVictor Musiime
Joint Clinical Research Centre JCRC, Kampala, Uganda
AIDS Res Hum Retroviruses 29:449-55. 2013..Multiple RAMs were observed among HIV-1-infected children with virological failure on first-line ART with M184V and K103N most frequent. The children responded favorably to boosted PI-based second-line ART...
Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of UgandaVictor Musiime
Joint Clinical Research Centre, Headquarters, Kampala, Uganda
AIDS Res Hum Retroviruses 28:1647-57. 2012..130), and in 78.8% of urban versus 88.8% of rural children by PC (p<0.0001). In this study rural children had more favorable clinical outcomes and were more likely to adhere optimally to ART than urban children...
Enteric bacterial pathogens in HIV-infected children with acute diarrhea in Mulago referral and teaching hospital, Kampala, UgandaVictor Musiime
Joint Clinical Research Centre, Clinic, Kampala, Uganda
J Int Assoc Physicians AIDS Care (Chic) 8:185-90. 2009..HIV-infected children develop severe bacterial infections. We set out to determine the enteric bacterial pathogens in HIV-infected children and HIV-negative controls with acute diarrhea and their antimicrobial sensitivities...
Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapineVictor Musiime
Joint Clinical Research Centre, Butikiro House, Kampala, Uganda
AIDS Res Hum Retroviruses 25:989-96. 2009....
A Case of Cryptococcal Lymphadenitis in an HIV-Infected ChildEva Natukunda
Joint Clinical Research Centre, Kampala, Uganda
AIDS Res Hum Retroviruses 27:373-6. 2011..Therefore cryptococcal lymphadenitis should be considered in the differential diagnosis of children presenting with lymphadenopathy and a positive serum CRAG...
Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW TrialVictor Musiime
Joint Clinical Research Centre, Kampala, Uganda
Antivir Ther 15:1115-24. 2010..We compared the pharmacokinetics (PK) of once- versus twice-daily lamivudine and abacavir treatment using the World Health Organization recommended weight band dosing of scored adult tablets...
